Prevention of radiation-induced xerostomia by submandibular gland transfer

Head and Neck

Volumn 34, Issue 7, 2012, Pages 937-942

  Zhang, Ye ^a   Guo, Chuan Bin ^a   Zhang, Lei ^a   Wang, Yang ^a   Peng, Xin ^a   Mao, Chi ^a   Yu, Guang Yan ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Dysphagia; Quality of life; Radiotherapy; Submandibular gland; Xerostomia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FLOW RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; ORAL SURGERY; OROPHARYNX CARCINOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INDUCED XEROSTOMIA; RADIATION INJURY; SALIVA ANALYSIS; SALIVATION; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND TRANSFER; SWALLOWING; XEROSTOMIA;

ADULT; AGED; DEGLUTITION; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; SALIVA; SUBMANDIBULAR GLAND; TREATMENT OUTCOME; XEROSTOMIA;

EID: 84862877666     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21859     Document Type: Article

References (21)

1. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 2007;29:387-400. (Pubitemid 46623504)
2. Jha N, Seikaly H, McGaw T, Coulter L. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 2000;46:7-11. (Pubitemid 30021472)
3. Hensley ML, Schuchter LM, Lindley C, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999; 17:3333-3355. (Pubitemid 29471562)
4. Sultanem K, Shu HK, Xia P, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 1999;48:711-722.
5. Saarilahti K, Kouri M, Collan J, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006;78: 270-275.
6. Fox PC, Weiffenbach JM, van der Ven PF, Baum BJ, Sonies BC. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985;110:519-525.
7. Dawes C. Factors influencing saliva flow rate and composition. In: Edgar WM, editor. Saliva and oral health. London: British Dental Association; 1996. pp27-41.
8. Saibishkumar EP, Jha N, Scrimger RA, et al. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study. Radiother Oncol 2007;85:98-104. (Pubitemid 47562588)
9. Seikaly H, Jha N, Harris JR, et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg 2004;130:956-961. (Pubitemid 39045603)
10. Seikaly H, Jha N, Mcgaw T, Coulter L, Liu R, Oldring D. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope 2001;111:347-352. (Pubitemid 32143759)
11. Jha N, Seikaly H, Harris J, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 2003; 66:283-289. (Pubitemid 36556047)
12. Spiegel JH, Brys AK, Bhakti A, Singer MI. Metastasis to the submandibular gland in head and neck carcinomas. Head Neck 2004; 30:1064-1068. (Pubitemid 39601227)
13. Jha N, Seikaly H, Harris J, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck 2009;31:234-243.
14. Bruce SD. Radiation-induced xerostomia: how dry is your patient?Clin J Oncol Nurs 2004;8:61-67.
15. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001;23:389-398.
16. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70. (Pubitemid 36959739)
17. Jabbari S, Kim H, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005;63: 725-731. (Pubitemid 41400058)
18. Logemann JA, Smith CH, Pauloski BR, et al. Effects of xerostomia on perception and performance of swallow function. Head Neck 2001;23: 317-321. (Pubitemid 32234110)
19. Logemann JA, Pauloski BR, Rademaker AW, et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 2003;25:432-437. (Pubitemid 36577026)
20. Rieger J, Seikaly H, Jha N, et al. Submandibular gland transfer for prevention of xerostomia after radiation therapy swallowing outcomes. Arch Otolaryngol Head Neck Surg 2005;131: 140-145. (Pubitemid 40204771)
21. Wu CH, Hsiao TY, Chen JC, Chang YC, Lee SY. Evaluation of swallowing safety with fiberoptic endoscope: comparison with videofluoroscopic technique. Laryngoscope 1997;107:396-401. (Pubitemid 27147513)